Patterns of premorbid functioning in first episode psychosis: Relationship to 2-year outcome

Acta Psychiatrica Scandinavica

Volumn 112, Issue 1, 2005, Pages 40-46

  Addington, Jean ^a,b,c   Addington, D ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Cognitive functioning; First episode; Outcome; Premorbid functioning; Schizophrenia; Symptoms

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

ACUTE PSYCHOSIS; ADOLESCENT; ADULT; ARTICLE; BRIEF PSYCHOTIC DISORDER; COGNITION; CONTROLLED STUDY; DELUSIONAL DISORDER; DEPRESSION; DETERIORATION; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEGATIVE SYNDROME; ONSET AGE; OUTCOMES RESEARCH; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL INTERACTION; SUBSTANCE ABUSE; VERBAL BEHAVIOR;

ADOLESCENT; ADULT; CHILD; CLUSTER ANALYSIS; COGNITION DISORDERS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; SOCIAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 21044443819     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2005.00511.x     Document Type: Article

References (47)

1. ADDINGTON J, ADDINGTON D. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J Psychiatr Neurosci 1993;18:18-23.
2. BAILER J, BRAUER W, REY ER. Premorbid adjustment as predictor of outcome in schizophrenia: Results of a prospective study. Acta Psychiatr Scand 1996;93:368-377.
3. GUPTA S, RAJAPRABHAKARAN R, ARNDT S, FLAUM M, ANDREASEN NC. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr Res 1995;16:189-197.
4. GUR RE, MOZLEY D, RESNICK SM et al., Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Arch Gen Psychiatry 1995;52:657-667.
5. KEEFE R, MOHS R, LOSONCZY M, DAVIDSON M. Premorbid sociosexual functioning and long-term outcome in schizophrenia. Am J Psychiatry 1989;146:206-211.
6. LEVITT J, O'DONNELL B, MCCARLEY R, NESTOR P, SHENTON M. Correlations of premorbid adjustment in schizophrenia with auditory event related potentials and neuropsychological abnormalities. Am J Psychiatry 1996;153:1347-1349.
7. NOPOULOS P, FLAUM M, ARNDT S, ANDREASEN N. Morphometry in schizophrenia revisited: height and its relationship to pre-morbid function. Psychol Med 1998;28:655-663.
8. VAN KAMMEN D, KELLY M, GILBERTSON M, GURKLIS J, O'CONNOR D. CSF Dopamine B-Hydroxylade in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures. Am J Psychiatry 1994;151:372-378.
9. HAAS GL, SWEENY JA. Premorbid and onset features of first-episode schizophrenia. Schizophr Bull 1992;18:373-386.
10. LARSEN TK, MCGLASHAN T, JOHANNESSEN J, VIBE-HANSEN L. First-episode schizophrenia: II. Premorbid patterns by gender. Schizophr Bull 1996;22:257-269.
11. AMMINGER GP, RESCH F, MUTSCHLECHNER R, FREDRICH MH, ERNST E. Premorbid adjustment and remission of positive symptoms in first-episode psychosis. Euro Child Adol Psychiatry 1997;6:212-218.
12. LARSEN TK, JOHANNESSEN JO, OPJORDSMOEN S. First-episode schizophrenia with long duration of untreated psychosis: Pathways to care. Br J Psychiatry 1998;172:45-52.
13. FANNON D, RILEY E, DOKU V, O'CEALLAIGH S, TENNAKOON L, CHITNIS X. Cognitive impairment predicted by the degree of premorbid deterioration in first episode psychosis. Schizophr Res 2000;41:45.
14. ROBINSON D, WOERNER MG, ALVIR JMJ et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;56:241-247.
15. LARSEN TK, MOE LC, VIBE-HANSEN L, JOHANNESSEN JO. Pre-morbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr Res 2000;45:1-9.
16. LARSEN TK, FRIIS S, MELLE IU et al. Premorbid functioning in first episode psychosis. Schizophr Res 2002;53:56-57.
17. HAAS GL, KESHAVAN MS, DICKEY JA, SWEENY JA, DEW MA. Patterns of premorbid psychosocial dysmaturation predict neurocognitive deficits in working memory and psychomotor speed. Schizophr Res 2001;49:108.
18. DICKEY WC, HAAS GL, SWEENEY JA. Post-pubertal behavioral decline as a predictor of symptomatology in first-episode schizophrenia. Schizophr Res 2001;49:16.
19. ADDINGTON J, VAN MASTRIGT S, ADDINGTON D. Patterns of premorbid functioning in first episode psychosis: initial presentation. Schizophr Res 2003;62:23-30.
20. ADDINGTON J, ADDINGTON D. Early intervention for psychosis: the calgary early psychosis treatment & prevention program. Can Psychiat Assoc Bull 2001;33:11-16.
21. DAVIS JM. Organic therapies: antipsychotic drugs. In: KAPLAN HI, SADDOCK BJ, eds. Comprehensive textbook of psychiatry/IV, Vol. 2, 4th edn. Baltimore, MD: Williams and Wilkins, 1985:1481-1513.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
23. SPITZER RL, WILLIAMS JB, GIBBON M, FIRST M. User's guide for the structured clinical interview for DSM III-R SCID. Washington, DC: American Psychiatric Press Inc., 1990.
24. CANNON-SPOOR HE, POTKIN SG, WYATT RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982;8:470-484.
25. VAN MASTRIGT S, ADDINGTON J. The assessment of premorbid functioning in first episode schizophrenia. J Psychiatry Neurosci 2002;27:92-101.
26. ADDINGTON J, VAN MASTRIGT S, ADDINGTON D. Duration of untreated psychosis: impact on two year outcome. Psychol Med 2004;34:277-284.
27. KAY SR, FIZBEIN A, OPLER LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
28. HEINRICHS DW, HANLON T E, CARPENTER WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984;10:388-398.
29. DRAKE RE, OSHER FC, NOORDSY DL, HURLBUT SC, TEAGUE GB, BEAUDETT MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57-67.
30. BENTON AL, HAMSHER K. Multilingual aphasia examination. Iowa City, IO: AHA Associates, 1983.
31. TOMBAUGH TN, KOZAK J, REES L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsych 1999;14:167-177.
32. MATHEWS CG, KLOVE N. Instruction manual for the adult neuropsychological test battery. Madison, WI: University of Madison Medical School, 1964.
33. REITAN R, WOLFSON D. The Halstead-Reitan neuropsychological test battery. Tucson, AZ: Neuropsychology Press, 1985.
34. LEZAK MD. Neuropsychological assessment. New York, NY: Oxford University Press, 1995:438-442.
35. REY A. L'examen clinique en psychologie. Paris: Presse Universitaire de France, 1958.
36. HEATON RK. Wisconsin card sorting test manual. Odessa. FL: Psychological Assessment Resources, 1981.
37. NUECHTERLEIN KH. Vigilance in schizophrenia and related disorders. In: STEINHAUER SR, GRUZELIER JH, ZUBIN J, eds. Handbook of schizophrenia, Vol. 5: neuropsychology, psychophysiology and information processing. Amsterdam: Elsevier, 1991:397-433.
38. ASARNOW RF, GRANHOLM E, SHERMAN T. Span of apprehension in schizophrenia. In: STEINHAUER SR, GRUZELIER JH, ZUBIN J, eds. Handbook of Schizophrenia, Vol. 5: Neuropsychology, psychophysiology and information processing. Amsterdam: Elsevier, 1991:335-370.
39. ADDINGTON J, YOUNG J, ADDINGTON D. Social outcome in early psychosis. Psychol Med 2003;33:1119-1124.
40. HAFNER H, RICCHER-ROSSLER A, MAURER K, FATKENHEUER B, LOFFLER W. First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences. Eur Arch Psychiatry Clin Neurosci 1992;242:109-118.
41. ADDINGTON J, ADDINGTON D. Cognitive functioning in first episode schizophrenia. J Psychiatry Neurosci 2002;27:188-192.
42. ADDINGTON J. Negative symptoms and the relationship to cognitive functioning. In: SHARMA T, HARVEY P, eds. Cognition in Schizophrenia. Oxford, UK: Oxford University Press, 2000:191-209.
43. JONES P, RODGERS B, MURRAY R, MARMOT M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994;344:1398-1402.
44. NUECHTERLEIN KH, DAWSON ME, GITLIN M et al. Developmental processes in schizophrenia disorders: longitudinal studies of vulnerability and stress. Schizophr Bull 1992;18:387-425.
45. ADDINGTON J, LERIGER E, ADDINGTON D. Symptom outcome one year after admission to an early psychosis program. Can J Psychiatr 2003;48:204-207.
46. LIEBERMAN J, JODY D, GEISLER S et al. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369-376.
47. TOHEN M, STRAKOWSKI SM, ZARATE CA et al. The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry 2000;48:467-476.